TNXP Bathi mangsa ngarep Tonix Pharma

Simbol resmi perusahaan Tonix Pharma (TNXP)

Effective distribution of stress and pain relief medications relies on strict inventory control, which supports the profit change forecast for Tonix Pharmaceuticals (TNXP). The value 0.02 characterizes this valuation parameter. Synthesis robotization and AI-driven trial analysis accelerate formula approvals, while the development of the CNS drug ecosystem is constrained by costs and FDA oversight.

tonixpharma.com (TNXP): Bathi resik sing dikarepake saka 21.03.2025 nganti 21.03.2025

Tonix Pharmaceuticals Inc. - rincian analitis lan metrik utama (TNXP)

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:TNXP, Tonix Pharmaceuticals Holding Corp.
Produk dadi Tonix Pharma

The commercialization potential of Tonmya for the treatment of PTSD and fibromyalgia directly determines the projected profit trajectory of Tonix Pharmaceuticals (TNXP). This indicator measures the dynamics of expected revenues in real-time, allowing investors to assess the resilience of the business model through the lens of macroeconomic shifts and confirm the long-term consensus asset valuation, thereby eliminating the risk of overpaying for unjustified optimism.

Analisis pesaing Tonix Pharmaceuticals

Bathi mangsa ngarep HLN|Proyeksi bathi mangsa ngarep Kenvue Corp|Bathi mangsa ngarep VRNA (Verona Pharma Corp)|MENS (Jyong Bio) - Penghasilan resik sing dikarepake|Bathi sing dikarepake Ligand Pharmaceuticals Incorporated LGND|Amneal (AMRX) - Bathi resik sing dikarepake|PRGO: Bathi mangsa ngarep|Alvotech SA - Bathi resik mangsa ngarep|LQDA: Proyeksi bathi mangsa ngarep|Galapagos Genomics - Penghasilan resik sing dikarepake|ANIP (ANI Pharmaceuticals Inc) - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake mannkindcorp.com MNKD|Bathi sing dikarepake Amphastar Pharmaceuticals, Inc. (AMPH)|PCRX (Pacira Pharmaceuticals) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep SPRY (ARS Pharmaceuticals Inc)|Bathi resik mangsa ngarep TBPH (Theravance)|AQST - Bathi sing dikarepake|scPharmaceuticals (SCPH) - Bathi mangsa ngarep|TECX: Proyeksi bathi mangsa ngarep|SXTC - Prakiraan bathi perusahaan|Bathi sing dikarepake eupraxiapharma.com|BHST: Penghasilan resik sing dikarepake|Bathi mangsa ngarep EXOZ (Invizyne Technologies)|ORMP - Bathi resik sing dikarepake|Proyeksi bathi mangsa ngarep ENTX (Entera Bio Ltd)|Proyeksi bathi mangsa ngarep MindWalk Holdings, Inc. HYFT|ABVC BioPharma, Inc - Proyeksi bathi mangsa ngarep|CPIX: Bathi sing dikarepake|QNTM (Quantum BioPharma Ltd) - Bathi mangsa ngarep|Prakiraan bathi resik FGEN|Bathi sing dikarepake Telomir Pharmaceuticals|RANI: Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep SNYR|Bathi mangsa ngarep Rallybio Corp RLYB|Bathi sing dikarepake Lexaria Bioscience Corp. LEXX|Prakiraan bathi perusahaan pulmatrix.com (PULM)|Pheton Holdings Limited - Proyeksi bathi mangsa ngarep|Bathi forward APM|LYRA (Lyra Therapeutics Inc.) - Bathi mangsa ngarep|IBO - Prakiraan bathi perusahaan|Bathi mangsa ngarep TNFA|Prakiraan bathi resik YCBD (cbdmd.com)|Bathi mangsa ngarep PRFX (PainReform Ltd)|CYTO: Bathi forward|Proyeksi bathi mangsa ngarep LIPO (lipella.com)|Bathi resik mangsa ngarep OPTN (OptiNose Corp)|PIRS: Bathi mangsa ngarep|PROC - Proyeksi bathi mangsa ngarep|PTPI: Proyeksi bathi mangsa ngarep|Qilian International Holding Group (QLI) - Proyeksi bathi mangsa ngarep|SLRN (ACELYRIN, Inc.) - Proyeksi bathi mangsa ngarep|TFF Pharmaceuticals (TFFP) - Prakiraan bathi perusahaan